LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia
Clinical trial NCT00936611 · COMPLETED
Trial details
- NCT number
- NCT00936611
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-09-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.